Oncothyreon (ONTY) Tops Q3 EPS by 4c

Oncothyreon (NASDAQ: ONTY) reported Q3 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Oncothyreon (ONTY) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Workhorse Group (WKHS) Misses Q2 EPS by 77c